These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27207391)

  • 21. [The use of implantable cardioverter-defibrillators (ICD) in children and adolescents].
    Apitz C; Gass M; Dörnberger V; Kuehlkamp V; Hofbeck M
    Klin Padiatr; 2006; 218(5):270-5. PubMed ID: 16947095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population.
    Stephenson EA; Batra AS; Knilans TK; Gow RM; Gradaus R; Balaji S; Dubin AM; Rhee EK; Ro PS; Thøgersen AM; Cecchin F; Triedman JK; Walsh EP; Berul CI
    J Cardiovasc Electrophysiol; 2006 Jan; 17(1):41-6. PubMed ID: 16426398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantable cardioverter defibrillator therapy in children with long QT syndrome.
    Goel AK; Berger S; Pelech A; Dhala A
    Pediatr Cardiol; 2004; 25(4):370-8. PubMed ID: 14994181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inappropriate ICD shocks in pediatrics and congenital heart disease patients: Risk factors and programming strategies.
    Garnreiter JM; Pilcher TA; Etheridge SP; Saarel EV
    Heart Rhythm; 2015 May; 12(5):937-42. PubMed ID: 25620047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardioverter-defibrillator implantations without thoracotomy: clinical experience with various electrode configurations and defibrillation wave forms of an endocardial/subcutaneous defibrillator system].
    Neuzner J; Huth C; Friedl A; Reinisch P; Pitschner HF; Schlepper M
    Z Kardiol; 1993 Feb; 82(2):99-107. PubMed ID: 8465572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: analysis from the LEADER registry.
    Sadoul N; Defaye P; Mouton E; Bizeau O; Dupuis JM; Blangy H; Delarche N; Blanc JJ; Lazarus A;
    Arch Cardiovasc Dis; 2013 Nov; 106(11):562-9. PubMed ID: 24200925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Midterm Results of Implantable Cardioverter Defibrillators in Children and Young Adults from a Single Center in Turkey.
    Aykan HH; Karagoz T; Gulgun M; Ertugrul I; Aypar E; Ozer S; Alehan D; Celiker A; Ozkutlu S
    Pacing Clin Electrophysiol; 2016 Nov; 39(11):1225-1239. PubMed ID: 27620455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. System survival of nontransvenous implantable cardioverter-defibrillators compared to transvenous implantable cardioverter-defibrillators in pediatric and congenital heart disease patients.
    Radbill AE; Triedman JK; Berul CI; Fynn-Thompson F; Atallah J; Alexander ME; Walsh EP; Cecchin F
    Heart Rhythm; 2010; 7(2):193-8. PubMed ID: 20022820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lesion-specific differences for implantable cardioverter defibrillator therapies in adults with congenital heart disease.
    Kella DK; Merchant FM; Veledar E; Book W; Lloyd MS
    Pacing Clin Electrophysiol; 2014 Nov; 37(11):1492-8. PubMed ID: 24889130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical impact of defibrillation testing at the time of implantable cardioverter-defibrillator insertion.
    Hadid C; Atienza F; Strasberg B; Arenal Á; Codner P; González-Torrecilla E; Datino T; Percal T; Almendral J; Ortiz M; Martins R; Martinez-Alzamora N; Fernandez Aviles F
    Cardiol J; 2015; 22(3):253-9. PubMed ID: 25179316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel use of a subcutaneous shock lead to create an epicardial implantable cardioverter/defibrillator system via a limited thoracotomy.
    Beelen R; Casselman F; Geelen P
    Acta Cardiol; 2009 Oct; 64(5):665-6. PubMed ID: 20058513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of ventricular tachyarrhythmias with an implantable pacemaker-cardioverter-defibrillator].
    Ohm OJ; Faerestrand S; Engedal H; Hegbom F; Stangeland L; Hoff PI
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):182-9. PubMed ID: 8430397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of defibrillation threshold testing during implantable cardioverter-defibrillator placement: data from the Israeli ICD Registry.
    Arnson Y; Suleiman M; Glikson M; Sela R; Geist M; Amit G; Schliamser JE; Goldenberg I; Ben-Zvi S; Orvin K; Rosenheck S; Adam Freedberg N; Strasberg B; Haim M
    Heart Rhythm; 2014 May; 11(5):814-21. PubMed ID: 24486799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.
    Weinstock J; Bader YH; Maron MS; Rowin EJ; Link MS
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?
    Koyak Z; de Groot JR; Van Gelder IC; Bouma BJ; van Dessel PF; Budts W; van Erven L; van Dijk AP; Wilde AA; Pieper PG; Sieswerda GT; Mulder BJ
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):101-10. PubMed ID: 22095638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cardioverter-defibrillator implantation in a patient with persistent left superior vena cava--a case report].
    Kempa M; Lubiński A; Wilczek R; Królak T; Pazdyga A; Raczak G
    Kardiol Pol; 2006 Nov; 64(11):1281-3. PubMed ID: 17165164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defibrillation threshold decrease with the supradiaphragmatic extracardiac implantable cardioverter-defibrillator implantation technique.
    Berruezo A; Zeljko HM; Bartrons J; Mayol J; Prada F; Brugada J
    Europace; 2010 Nov; 12(11):1649-51. PubMed ID: 20543197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of children and young adults treated with implantable cardioverter-defibrillator: the authors' own experience with optimal implantable cardioverter-defibrillator programming.
    Lewandowski M; Sterlinski M; Maciag A; Syska P; Kowalik I; Szwed H; Chojnowska L; Przybylski A
    Europace; 2010 Sep; 12(9):1245-50. PubMed ID: 20650939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fifteen years' experience of implantable cardioverter defibrillator in children and young adults: Mortality and complications study.
    Lewandowski M; Syska P; Kowalik I; Maciąg A; Sterliński M; Ateńska-Pawłowska J; Szwed H
    Pediatr Int; 2018 Oct; 60(10):923-930. PubMed ID: 29998526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.